tositumomab (I 131 tositumomab)

tositumomab (I 131 tositumomab) is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Genetic Implications: Genetic Implications

**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.

Pronunciation:
to-si-too-mo-mab

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Bexxar

Ther. Class.
antineoplastics

Pharm. Class.
monoclonal antibodies (radiolabled monoclonal antibodies)

-- To view the remaining sections of this topic, please or --

General

Genetic Implications: Genetic Implications

**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.

Pronunciation:
to-si-too-mo-mab

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Bexxar

Ther. Class.
antineoplastics

Pharm. Class.
monoclonal antibodies (radiolabled monoclonal antibodies)

There's more to see -- the rest of this entry is available only to subscribers.